Yahoo Finance

Prokaryotics Announces Licensing Agreement with Northern Antibiotics for Novel Gram-negative Antibiotic Potentiator

UNION, N.J., June 26, 2025 /PRNewswire/ -- Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it ...
GEN

Spero Therapeutics Wins $1.65M DoD Award toward Potentiator Program

Spero Therapeutics said today it was won a $1.65 million award from the U.S. Department of Defense (DoD) toward developing its anti-infective Potentiator program and advancing the best candidates ...
Business Wire

Enterprise Therapeutics’ First-in-Class TMEM16A potentiator program for treatment of cystic fibrosis and other respiratory diseases acquired by Roche

BRIGHTON, England--(BUSINESS WIRE)--Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients ...
BioWorld

GABA-A receptor potentiator KRM-II-81 blocks pain-like behaviors in rats

Respirerx Pharmaceuticals Inc.’s lead GABA-A receptor potentiator, KRM-II-81, has advanced to the next level of evaluation within the National Institutes of Health (NIH) HEAL Initiative Preclinical ...
Business Wire

Forbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by Roche

NAARDEN, The Netherlands & BRIGHTON, England--(BUSINESS WIRE)--Forbion, a leading European life sciences venture capital firm, today announces that its portfolio company, Enterprise Therapeutics Ltd ...